JAFL
TNGX icon

Jay A. Fishman Ltd’s Tango Therapeutics TNGX Stock Holding History

Jay A. Fishman Ltd’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-19,000
Closed -$163K – 92
2024
Q2 		$163K Sell
19,000
-5,000
-21% -$38.6K 0.02% 85
2024
Q1 		$191K Buy
24,000
+10,000
+71% +$107K 0.02% 87
2023
Q4 		$139K Hold
14,000
– – 0.02% 90
2023
Q3 		$158K Sell
14,000
-6,000
-30% -$36.6K 0.02% 94
2023
Q2 		$66.4K Buy
20,000
+10,000
+100% +$36K 0.01% 97
2023
Q1 		$39.5K Hold
10,000
– – 0.01% 93
2022
Q4 		$72.5K Buy
+10,000
New +$70.3K 0.01% 96

Other funds holding TNGX

TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return